# US 2013/0252282 A1 · Optical control of protein activity and localization by fusion to photochromic protein domains

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252282 A1
- Document ID: US20130252282A1
- Status: Published application
- Kind: A1
- Application number: 13/848,346
- Filed: 2013-03-21
- Published: 2013-09-26
- Earliest claimed: 2012-03-22
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Inventors: Xin Zhou; Michael Z. Lin
- Web page: https://patentgrep.com/patent/US20130252282A1

## CPC

- C12N 13/00: Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
- C07K 14/001: {by chemical synthesis}
- C12Q 1/02: involving viable microorganisms
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Engineered fusion proteins comprising photochromic protein domains are disclosed. In particular, the inventors have constructed fusion proteins containing photoswitchable photochromic fluorescent protein domains linked to selected proteins and shown that such fusion proteins can be used to control the activity or localization of selected proteins with light.

## Claims

### Claim 1

A fusion protein comprising at least two photochromic polypeptides connected to a selected polypeptide of interest, wherein a first photochromic polypeptide is connected to the N-terminus of the selected polypeptide of interest and a second photochromic polypeptide is connected to the C-terminus of the selected polypeptide of interest, wherein the oligomerization state of the first photochromic polypeptide and the second photochromic polypeptide is controllable with light.

### Claim 2 (depends on 1)

The fusion protein of claim 1, wherein at least one photochromic polypeptide is selected from the group consisting of a Dronpa polypeptide, a Padron polypeptide, an rsTagRFP polypeptide, and an mApple polypeptide.

### Claim 3 (depends on 2)

The fusion protein of claim 2, comprising two Dronpa-145N polypeptides.

### Claim 4 (depends on 2)

The fusion protein of claim 2, comprising a Dronpa-145K polypeptide and a Dronpa-145N polypeptide.

### Claim 5 (depends on 2)

The fusion protein of claim 2, wherein at least one photochromic polypeptide comprises:
a) an amino acid sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9; or
b) an amino acid sequence having at least 95% identity to an amino acid sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9, wherein the photochromic polypeptide has fluorescence and oligomerization characteristics.

### Claim 6 (depends on 1)

The fusion protein of claim 1, further comprising a targeting sequence.

### Claim 7 (depends on 1)

The fusion protein of claim 1, further comprising a tag.

### Claim 8 (depends on 1)

The fusion protein of claim 1, wherein the selected polypeptide of interest comprises a sequence from a protein selected from the group consisting of a membrane protein, a receptor, a hormone, a transport protein, a transcription factor, a cytoskeletal protein, an extracellular matrix protein, a signal-transduction protein, and an enzyme.

### Claim 9 (depends on 1)

The fusion protein of claim 1, wherein the selected polypeptide of interest comprises a biologically active domain selected from the group consisting of a catalytic domain, a ligand binding domain, and a protein-protein interaction domain.

### Claim 10 (depends on 1)

A method for controlling the activity of a selected polypeptide of interest with light, the method comprising:
a) preparing a fusion protein according to claim 1; and
b) illuminating the fusion protein with light at a wavelength that induces intramolecular dimerization of the first photochromic polypeptide and the second photochromic polypeptide, such that the activity of the selected polypeptide of interest is inactivated.

### Claim 11 (depends on 10)

The method of claim 10, further comprising illuminating the fusion protein with light at a wavelength that induces dissociation of the first photochromic polypeptide from the second photochromic polypeptide, such that the activity of the selected polypeptide is restored.

### Claim 12 (depends on 10)

The method of claim 10, further comprising visualizing the localization of the selected polypeptide by detecting fluorescence of the fusion protein resulting from the dimerization of the first photochromic polypeptide and the second photochromic polypeptide.

### Claim 13 (depends on 10)

The method of claim 10, further comprising detecting inactivation of the selected polypeptide by measuring fluorescence from dimerization of the first photochromic polypeptide and the second photochromic polypeptide.

### Claim 14 (depends on 10)

The method of claim 10, further comprising detecting inactivation of the selected polypeptide by measuring the activity of the selected polypeptide.

### Claim 15 (depends on 10)

The method of claim 10, wherein fluorescence of the fusion protein is detected by a fluorimeter, a fluorescence microscope, a fluorescence microplate reader, a fluorometric imaging plate reader, or fluorescence-activated cell sorting.

### Claim 16 (depends on 10)

The method of claim 10, wherein the first photochromic polypeptide and the second photochromic polypeptide are selected from the group consisting of a Dronpa polypeptide, a Padron polypeptide, an rsTagRFP polypeptide, and an mApple polypeptide.

### Claim 17 (depends on 16)

The method of claim 16, wherein the first photochromic polypeptide or the second photochromic polypeptide comprises:
a) an amino acid sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9; or
b) an amino acid sequence having at least 95% identity to an amino acid sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9, wherein the polypeptide has fluorescence and oligomerization characteristics.

### Claim 18

A method for controlling the localization of a selected polypeptide of interest with light, the method comprising:
a) preparing a first fusion protein comprising a photochromic polypeptide connected to a targeting sequence;
b) preparing a second fusion protein comprising a photochromic polypeptide connected to the selected polypeptide of interest;
c) introducing the first fusion protein and the second fusion protein into a cell, wherein the localization sequence targets the first fusion protein to a particular subcellular location;
d) illuminating the fusion proteins with light at a wavelength that induces oligomerization of the photochromic polypeptide in the first fusion protein with the photochromic polypeptide in the second fusion protein, such that the selected polypeptide accumulates at the subcellular location.

### Claim 19 (depends on 18)

The method of claim 18, further comprising illuminating the fusion protein with light at a wavelength that induces dissociation of the photochromic polypeptides, such that the selected polypeptide in the second fusion protein is released from the subcellular location.

### Claim 20 (depends on 18)

The method of claim 18, further comprising visualizing the localization of the selected polypeptide by detecting fluorescence of the fusion protein resulting from the oligomerization of the photo chromic polypeptides.

### Claim 21 (depends on 18)

The method of claim 18, wherein the targeting sequence is selected from the group consisting of a secretory protein signal sequence, a membrane protein signal sequence, a nuclear localization sequence, a nucleolar localization signal sequence, an endoplasmic reticulum localization sequence, a peroxisome localization sequence, a mitochondrial localization sequence, and a protein binding motif sequence.

### Claim 22 (depends on 18)

The method of claim 18, wherein fluorescence of the fusion proteins are detected by a fluorometer, a fluorescence microscope, a fluorescence microplate reader, a fluorometric imaging plate reader, or fluorescence-activated cell sorting.

### Claim 23 (depends on 18)

The method of claim 18, wherein the photochromic polypeptide in the first fusion protein and the photochromic polypeptide in the second fusion protein are selected from the group consisting of a Dronpa polypeptide, a Padron polypeptide, an rsTagRFP polypeptide, and an mApple polypeptide.

### Claim 24 (depends on 23)

The method of claim 23, wherein the photochromic polypeptide of the first fusion protein or the second fusion protein comprises:
a) an amino acid sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9; or
b) an amino acid sequence having at least 95% identity to an amino acid sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9.

### Claim 25

A method for controlling the localization of a selected polypeptide of interest with light, the method comprising:
a) preparing a fusion protein comprising a photochromic polypeptide, a targeting sequence, and the selected polypeptide of interest;
b) introducing the fusion protein into a cell, wherein the localization sequence targets the fusion protein to a particular subcellular location;
c) illuminating the fusion protein with light at a wavelength that induces oligomerization of the photochromic polypeptide in the fusion protein with photochromic polypeptides in other fusion proteins, said other fusion proteins comprising the selected polypeptide of interest, such that the selected polypeptide of interest accumulates at the subcellular location.

### Claim 26 (depends on 25)

The method of claim 25, further comprising illuminating the fusion protein with light at a wavelength that induces dissociation of the photochromic polypeptides, such that the selected polypeptide of interest in the fusion protein is released from the subcellular location.

### Claim 27 (depends on 25)

The method of claim 25, further comprising visualizing the localization of the selected polypeptide of interest by detecting fluorescence of the fusion protein resulting from the oligomerization with photochromic polypeptides of the other fusion proteins.

### Claim 28 (depends on 25)

The method of claim 25, wherein the targeting sequence is selected from the group consisting of a secretory protein signal sequence, a membrane protein signal sequence, a nuclear localization sequence, a nucleolar localization signal sequence, an endoplasmic reticulum localization sequence, a peroxisome localization sequence, a mitochondrial localization sequence, and a protein binding motif sequence.

### Claim 29 (depends on 25)

The method of claim 25, wherein the photochromic polypeptide of the fusion protein comprises an amino acid sequence selected from the group consisting of a Dronpa polypeptide, a Padron polypeptide, an rsTagRFP polypeptide, and an mApple polypeptide.

### Claim 30 (depends on 29)

The method of claim 29, wherein the photochromic polypeptide of the fusion protein comprises:
a) an amino acid sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9; or
b) an amino acid sequence having at least 95% identity to an amino acid sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9, wherein the photochromic polypeptide has fluorescence and oligomerization characteristics.

### Claim 31 (depends on 1)

A polynucleotide encoding the fusion protein of claim 1.

### Claim 32 (depends on 31)

A recombinant polynucleotide comprising the polynucleotide of claim 31 operably linked to a promoter.

### Claim 33 (depends on 32)

The recombinant polynucleotide of claim 32 comprising a polynucleotide selected from the group consisting of:
a) a polynucleotide encoding a polypeptide comprising a sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9;
b) a polynucleotide encoding a polypeptide comprising a sequence at least 95% identical to a sequence selected from the group consisting of SEQ ID NOS:1, 3, 5, 7, and 9, wherein the polypeptide has fluorescence characteristics;
c) a polynucleotide comprising a sequence selected from the group consisting of SEQ ID NOS:2, 4, 6, 8, and 10; and
d) a polynucleotide comprising a sequence at least 95% identical to a sequence selected from the group consisting of SEQ ID NOS:2, 4, 6, 8, and 10, wherein the polynucleotide encodes a polypeptide having fluorescence characteristics.

### Claim 34 (depends on 32)

A host cell comprising the recombinant polynucleotide of claim 32.

### Claim 35 (depends on 32)

A method for producing a fusion protein, the method comprising:
a) transforming a host cell with the recombinant polynucleotide of claim 32;
b) culturing the transformed host cell under conditions whereby the fusion protein is expressed; and
c) isolating the fusion protein from the host cell.

### Claim 36 (depends on 1)

A kit comprising the fusion protein of claim 1.

### Claim 37 (depends on 32)

A kit comprising the recombinant polynucleotide of claim 32.

### Claim 38 (depends on 34)

A kit comprising the host cell of claim 34.
